Compare JYD & FEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JYD | FEED |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | China | United States |
| Employees | N/A | 14 |
| Industry | Oil Refining/Marketing | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.6M |
| IPO Year | 2022 | N/A |
| Metric | JYD | FEED |
|---|---|---|
| Price | $0.77 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 346.9K | ★ 595.7K |
| Earning Date | 05-15-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.63 |
| 52 Week High | $6.85 | $6.09 |
| Indicator | JYD | FEED |
|---|---|---|
| Relative Strength Index (RSI) | 29.70 | 27.04 |
| Support Level | $0.54 | N/A |
| Resistance Level | $1.07 | $0.97 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 16.09 | 5.94 |
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, fragmented logistics, and chartered airline freight services, supply chain management, and other value-added services.
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.